Is Montelukast Indicated for Treatment of Chronic Rhinosinusitis With Polyposis?

被引：23
作者：
Smith, Timothy L.
Sautter, Nathan B.
机构：
[1] Oregon Sinus Ctr, Div Rhinol & Sinus Surg, Dept Otolaryngol Head & Neck Surg, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97239 USA
来源：
LARYNGOSCOPE | 2014年 / 124卷 / 08期
关键词：
LEUKOTRIENE RECEPTOR ANTAGONIST; NASAL POLYPOSIS; ASTHMA;
D O I：
10.1002/lary.24477
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1735 / 1736
页数：2
相关论文
共 5 条
  • [1] Targeting Ca2+ release-activated Ca2+ channel channels and leukotriene receptors provides a novel combination strategy for treating nasal polyposis
    Di Capite, Joseph
    Nelson, Charmaine
    Bates, Grant
    Parekh, Anant B.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (05) : 1014 - 1021
  • [2] An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma
    Ragab, S
    Parikh, A
    Darby, YC
    Scadding, GK
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (09) : 1385 - 1391
  • [3] Schäper C, 2011, J INVEST ALLERG CLIN, V21, P51
  • [4] Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis
    Stewart, Rosemary A.
    Ram, Bhaskar
    Hamilton, Garun
    Weiner, John
    Kane, Kevin J.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 139 (05) : 682 - 687
  • [5] Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps
    Vuralkan, Erkan
    Saka, Cem
    Akin, Istemihan
    Hucumenoglu, Sema
    Unal, Binnur Uzmez
    Kuran, Gokhan
    Ocal, Berrak
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (01) : 5 - 10
1